List of Tables
Table 1. GPCR-targeting Drug Market Trends
Table 2. GPCR-targeting Drug Market Drivers & Opportunity
Table 3. GPCR-targeting Drug Market Challenges
Table 4. GPCR-targeting Drug Market Restraints
Table 5. Global GPCR-targeting Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global GPCR-targeting Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies GPCR-targeting Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies GPCR-targeting Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of GPCR-targeting Drug
Table 10. Global GPCR-targeting Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GPCR-targeting Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global GPCR-targeting Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global GPCR-targeting Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global GPCR-targeting Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global GPCR-targeting Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global GPCR-targeting Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global GPCR-targeting Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global GPCR-targeting Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global GPCR-targeting Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global GPCR-targeting Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global GPCR-targeting Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global GPCR-targeting Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global GPCR-targeting Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global GPCR-targeting Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global GPCR-targeting Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global GPCR-targeting Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions GPCR-targeting Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions GPCR-targeting Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions GPCR-targeting Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. PerkinElmer Basic Information List
Table 32. PerkinElmer Description and Business Overview
Table 33. PerkinElmer GPCR-targeting Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in GPCR-targeting Drug Business of PerkinElmer (2019-2024)
Table 35. PerkinElmer Recent Developments
Table 36. Thermo Fisher Scientific Basic Information List
Table 37. Thermo Fisher Scientific Description and Business Overview
Table 38. Thermo Fisher Scientific GPCR-targeting Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in GPCR-targeting Drug Business of Thermo Fisher Scientific (2019-2024)
Table 40. Thermo Fisher Scientific Recent Developments
Table 41. Merck Basic Information List
Table 42. Merck Description and Business Overview
Table 43. Merck GPCR-targeting Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in GPCR-targeting Drug Business of Merck (2019-2024)
Table 45. Merck Recent Developments
Table 46. BD Biosciences Basic Information List
Table 47. BD Biosciences Description and Business Overview
Table 48. BD Biosciences GPCR-targeting Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in GPCR-targeting Drug Business of BD Biosciences (2019-2024)
Table 50. BD Biosciences Recent Developments
Table 51. Molecular Devices Basic Information List
Table 52. Molecular Devices Description and Business Overview
Table 53. Molecular Devices GPCR-targeting Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in GPCR-targeting Drug Business of Molecular Devices (2019-2024)
Table 55. Molecular Devices Recent Developments
Table 56. Promega Basic Information List
Table 57. Promega Description and Business Overview
Table 58. Promega GPCR-targeting Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in GPCR-targeting Drug Business of Promega (2019-2024)
Table 60. Promega Recent Developments
Table 61. Qiagen Basic Information List
Table 62. Qiagen Description and Business Overview
Table 63. Qiagen GPCR-targeting Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in GPCR-targeting Drug Business of Qiagen (2019-2024)
Table 65. Qiagen Recent Developments
Table 66. Abcam Basic Information List
Table 67. Abcam Description and Business Overview
Table 68. Abcam GPCR-targeting Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in GPCR-targeting Drug Business of Abcam (2019-2024)
Table 70. Abcam Recent Developments
Table 71. Corning Basic Information List
Table 72. Corning Description and Business Overview
Table 73. Corning GPCR-targeting Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in GPCR-targeting Drug Business of Corning (2019-2024)
Table 75. Corning Recent Developments
Table 76. Discoverx Basic Information List
Table 77. Discoverx Description and Business Overview
Table 78. Discoverx GPCR-targeting Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in GPCR-targeting Drug Business of Discoverx (2019-2024)
Table 80. Discoverx Recent Developments
Table 81. Cisbio Basic Information List
Table 82. Cisbio Description and Business Overview
Table 83. Cisbio GPCR-targeting Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in GPCR-targeting Drug Business of Cisbio (2019-2024)
Table 85. Cisbio Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. GPCR-targeting Drug Downstream Customers
Table 89. GPCR-targeting Drug Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. GPCR-targeting Drug Product Picture
Figure 2. Global GPCR-targeting Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global GPCR-targeting Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. GPCR-targeting Drug Report Years Considered
Figure 5. Global GPCR-targeting Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by GPCR-targeting Drug Revenue in 2023
Figure 7. GPCR-targeting Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Reagent Test Kit Picture
Figure 9. Substrate Picture
Figure 10. Global GPCR-targeting Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global GPCR-targeting Drug Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Oncology
Figure 13. Product Picture of Cardiovascular
Figure 14. Product Picture of Central Nervous
Figure 15. Product Picture of Other
Figure 16. Global GPCR-targeting Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global GPCR-targeting Drug Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America GPCR-targeting Drug Sales Value (2019-2030) & (US$ Million)
Figure 19. North America GPCR-targeting Drug Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe GPCR-targeting Drug Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe GPCR-targeting Drug Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific GPCR-targeting Drug Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific GPCR-targeting Drug Sales Value by Country (%), 2023 VS 2030
Figure 24. South America GPCR-targeting Drug Sales Value (2019-2030) & (US$ Million)
Figure 25. South America GPCR-targeting Drug Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa GPCR-targeting Drug Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa GPCR-targeting Drug Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions GPCR-targeting Drug Sales Value (%), (2019-2030)
Figure 29. United States GPCR-targeting Drug Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States GPCR-targeting Drug Sales Value by Type (%), 2023 VS 2030
Figure 31. United States GPCR-targeting Drug Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe GPCR-targeting Drug Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe GPCR-targeting Drug Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe GPCR-targeting Drug Sales Value by Application (%), 2023 VS 2030
Figure 35. China GPCR-targeting Drug Sales Value, (2019-2030) & (US$ Million)
Figure 36. China GPCR-targeting Drug Sales Value by Type (%), 2023 VS 2030
Figure 37. China GPCR-targeting Drug Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan GPCR-targeting Drug Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan GPCR-targeting Drug Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan GPCR-targeting Drug Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea GPCR-targeting Drug Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea GPCR-targeting Drug Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea GPCR-targeting Drug Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia GPCR-targeting Drug Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia GPCR-targeting Drug Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia GPCR-targeting Drug Sales Value by Application (%), 2023 VS 2030
Figure 47. India GPCR-targeting Drug Sales Value, (2019-2030) & (US$ Million)
Figure 48. India GPCR-targeting Drug Sales Value by Type (%), 2023 VS 2030
Figure 49. India GPCR-targeting Drug Sales Value by Application (%), 2023 VS 2030
Figure 50. GPCR-targeting Drug Industrial Chain
Figure 51. GPCR-targeting Drug Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
